Stocklytics Platform
Asset logo for symbol SILO
Silo Pharma
SILO46
$1.13arrow_drop_down1.73%-$0.02
Penny Stock
Asset logo for symbol SILO
SILO46

$1.13

arrow_drop_down1.73%

Performance History

Chart placeholder
Key Stats
Open$1.14
Prev. Close$1.15
EPS-1.21
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$5.06M
PE Ratio-
LOWHIGH
Day Range1.09
1.25
52 Week Range0.84
4.50
Ratios
Revenue-
EBITDA Margin %-
EPS-1.21

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Silo Pharma (SILO)

Silo Pharma Inc. (SILO) is a biopharmaceutical company that focuses on developing and commercializing therapies for various medical conditions. The company's primary goal is to revolutionize the way diseases are treated by utilizing psychedelic compounds and other advanced technologies. With a mission to improve the quality of life for patients, Silo Pharma is committed to developing innovative solutions that address unmet medical needs.
The stock price history of Silo Pharma Inc. (SILO) shows a steady increase over the past year. Despite some fluctuations, the overall trend has been positive, indicating investor confidence in the company's future prospects. This positive sentiment is further supported by the recent news surrounding Silo Pharma Inc. (SILO).
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Eric Weisblum
Headquarters
Englewood Cliffs
Employees
3
Exchange
NASDAQ
add Silo Pharma to watchlist

Keep an eye on Silo Pharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Silo Pharma's (SILO) price per share?

The current price per share for Silo Pharma (SILO) is $1.13. The stock has seen a price change of -$0.02 recently, indicating a -1.74% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Silo Pharma (SILO)?

For Silo Pharma (SILO), the 52-week high is $4.5, which is 298.23% from the current price. The 52-week low is $0.84, the current price is 34.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Silo Pharma (SILO) a growth stock?

Silo Pharma (SILO) has shown an average price growth of -6.65% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Silo Pharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Silo Pharma (SILO) stock price performance year to date (YTD)?

As of the latest data, Silo Pharma (SILO) has a year-to-date price change of -25.66%. Over the past month, the stock has experienced a price change of -3.42%. Over the last three months, the change has been -24.16%. Over the past six months, the figure is -39.89%.
help

Is Silo Pharma (SILO) a profitable company?

Silo Pharma (SILO) has a net income of -$3.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -5.56K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$3.86M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Silo Pharma (SILO)?

Silo Pharma (SILO) has a market capitalization of $5.07M. The average daily trading volume is 1.16, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level